TrialBone marrow transplantation2006

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.

D Wolff et al.PubMed ↗Publisher ↗

No numbers read from the abstract.